SIGA Technologies, Inc. Board of Directors

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.

Ms. Tove C. Bolken

Ms. Tove C. Bolken

Senior VP of Operations & Chief Supply Chain Officer

Mr. Daniel J. Luckshire CPA

Mr. Daniel J. Luckshire CPA

Executive VP, CFO & Secretary

Mr. Herb Vloedman

Mr. Herb Vloedman

Senior VP & Chief Information Officer

Dr. Dennis E. Hruby Ph.D.

Dr. Dennis E. Hruby Ph.D.

Executive VP & Chief Scientific Officer

Comments